文献速递胸部肿瘤支持与姑息治疗

基于电子患者报告结局的症状管理对比常规护理在肺癌术后患者中的长期结果:一项多中心、随机、对照试验

Electronic Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized, Controlled Trial.
PubMed 文献 · J Clin Oncol · 2024-04-04

该多中心随机对照试验将肺癌术后患者1:1分配至基于电子患者报告结局(ePRO)的症状管理组或常规护理组,按方案分析纳入ePRO组55例、常规护理组57例。出院后12个月时,ePRO组的症状阈值事件显著少于常规护理组(中位[IQR] 0[0-0] vs 0[0-1],P=0.040),且出院后1至12个月期间躯体干扰和情感干扰复合评分持续显著低于常规护理组。

要点

  • 出院后12个月,ePRO组症状阈值事件中位0[0-0] vs 常规护理组0[0-1],P=0.040。
  • 出院后1至12个月,ePRO组躯体干扰复合评分估计值-0.86(95%CI -1.32至-0.39)。
  • 出院后1至12个月,ePRO组情感干扰复合评分估计值-0.70(95%CI -1.14至-0.26)。

核心结论

  • 肺癌术后早期强化ePRO症状管理可降低症状负担并改善功能状态,持续至出院后1年,支持将其整合入标准护理。

研究设计与样本

  • 多中心、随机、对照试验,患者1:1分配至术后基于ePRO的症状管理组或常规护理组。
  • 干预频率:术后每日、出院后每周两次至1个月、出院后3、6、9、12个月。
  • 长期患者报告结局采用MD Anderson症状量表-肺癌模块评估。
  • 按方案分析纳入ePRO组55例、常规护理组57例。

主要发现

  • 出院后12个月,ePRO组症状阈值事件(五个目标症状中任一评分≥4)中位[IQR]为0[0-0],常规护理组为0[0-1],P=0.040。
  • 出院后1至12个月,ePRO组躯体干扰复合评分估计值为-0.86(95%CI -1.32至-0.39)。
  • 出院后1至12个月,ePRO组情感干扰复合评分估计值为-0.70(95%CI -1.14至-0.26)。

关键数值与推荐

  • 症状阈值事件定义为五个目标症状中任一评分≥4。
  • 出院后12个月症状阈值事件中位[IQR]:ePRO组0[0-0] vs 常规护理组0[0-1],P=0.040。
  • 躯体干扰复合评分估计值-0.86(95%CI -1.32至-0.39),ePRO组低于常规护理组。
  • 情感干扰复合评分估计值-0.70(95%CI -1.14至-0.26),ePRO组低于常规护理组。

临床怎么用

  • 作者认为,肺癌术后早期强化ePRO症状管理可降低症状负担并改善功能状态至出院后1年,支持将其整合入标准护理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported.We previously reported superior symptom control of electronic patient-reported outcome (ePRO)-based symptom management after lung cancer surgery for up to 1 month postdischarge. Here, we present the long-term results (1-12 months) of this multicenter, randomized trial, where patients were assigned 1:1 to receive postoperative ePRO-based symptom management or usual care daily postsurgery, twice weekly postdischarge until 1 month, and at 3, 6, 9, and 12 months postdischarge. Long-term patient-reported outcomes were assessed with MD Anderson Symptom Inventory-Lung Cancer module. Per-protocol analyses were performed with 55 patients in the ePRO group and 57 in the usual care group. At 12 months postdischarge, the ePRO group reported significantly fewer symptom threshold events (any of the five target symptom scored ≥4; median [IQR], 0 [0-0] v 0 [0-1]; P = .040) than the usual care group. From 1 to 12 months postdischarge, the ePRO group consistently reported significantly lower composite scores for physical interference (estimate, -0.86 [95% CI, -1.32 to -0.39]) and affective interference (estimate, -0.70 [95% CI, -1.14 to -0.26]). Early intensive ePRO-based symptom management after lung cancer surgery reduced symptom burden and improved functional status for up to 1 year postdischarge, supporting its integration into standard care.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Dai W, Wang Y, Liao J, et al. Electronic Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized, Controlled Trial. J Clin Oncol. 2024. PMID: 38574304. doi:10.1200/JCO.23.01854

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。